Total Payments
$685,389
2024 Payments
$286,923
Companies
19
Transactions
548
Medicare Patients
2,614
Medicare Billing
$77,443
Payment Breakdown by Category
Other$564,379 (82.3%)
Travel$60,355 (8.8%)
Consulting$49,040 (7.2%)
Food & Beverage$11,615 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $564,379 | 147 | 82.3% |
| Travel and Lodging | $60,355 | 204 | 8.8% |
| Consulting Fee | $49,040 | 16 | 7.2% |
| Food and Beverage | $11,615 | 181 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $330,895 | 196 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $253,064 | 205 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $89,027 | 81 | $0 (2024) |
| Genentech USA, Inc. | $5,780 | 15 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $3,561 | 6 | $0 (2019) |
| GlaxoSmithKline, LLC. | $2,200 | 14 | $0 (2024) |
| Boston Scientific Corporation | $183.87 | 1 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $130.05 | 2 | $0 (2022) |
| Horizon Pharma plc | $120.94 | 6 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $81.94 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $286,923 | 175 | GENZYME CORPORATION ($153,770) |
| 2023 | $215,130 | 181 | GENZYME CORPORATION ($102,379) |
| 2022 | $109,121 | 93 | Regeneron Healthcare Solutions, Inc. ($50,786) |
| 2021 | $53,909 | 37 | GENZYME CORPORATION ($29,565) |
| 2020 | $5,578 | 9 | AstraZeneca Pharmaceuticals LP ($2,817) |
| 2019 | $11,263 | 22 | Genentech USA, Inc. ($5,647) |
| 2018 | $3,401 | 28 | Regeneron Healthcare Solutions, Inc. ($2,793) |
| 2017 | $64.59 | 3 | GlaxoSmithKline, LLC. ($34.35) |
All Payment Transactions
548 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,863.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,551.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Travel and Lodging | In-kind items and services | $908.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Travel and Lodging | In-kind items and services | $351.96 | General |
| Category: Immunology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $114.99 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,340.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,340.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,285.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,340.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,340.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $211.05 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $192.29 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $190.98 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $161.28 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.18 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $27.71 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $17.16 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $408.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,551.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $473.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $114.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,863.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 694 | 753 | $159,639 | $22,546 |
| 2022 | 8 | 663 | 742 | $120,348 | $17,776 |
| 2021 | 11 | 888 | 994 | $155,620 | $23,258 |
| 2020 | 11 | 369 | 419 | $85,335 | $13,863 |
Total Patients
2,614
Total Services
2,908
Medicare Billing
$77,443
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 48 | 95 | $35,569 | $7,324 | 20.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $26,093 | $3,469 | 13.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $24,624 | $3,413 | 13.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 113 | 114 | $25,682 | $2,009 | 7.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 27 | $7,702 | $1,827 | 23.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 164 | 166 | $14,820 | $1,566 | 10.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 148 | 149 | $9,768 | $1,062 | 10.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 19 | $4,593 | $902.40 | 19.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 86 | 86 | $8,098 | $699.46 | 8.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 41 | 42 | $2,690 | $275.20 | 10.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 47 | 85 | $28,660 | $6,845 | 23.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $16,712 | $2,886 | 17.3% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 107 | 115 | $24,852 | $2,088 | 8.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 15 | 16 | $10,164 | $1,802 | 17.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 163 | 171 | $14,604 | $1,673 | 11.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 155 | 160 | $10,070 | $1,171 | 11.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 90 | 107 | $8,890 | $723.55 | 8.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 69 | 71 | $6,396 | $587.26 | 9.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 43 | 75 | $24,432 | $6,153 | 25.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 19 | $17,892 | $3,125 | 17.5% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 141 | 150 | $31,320 | $2,848 | 9.1% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 216 | 226 | $18,726 | $2,316 | 12.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 18 | $13,956 | $2,003 | 14.4% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 209 | 219 | $13,412 | $1,675 | 12.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 12 | 13 | $6,697 | $1,412 | 21.1% |
About Steven White
Steven White is a Pulmonary Disease healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922161447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Steven White has received a total of $685,389 in payments from pharmaceutical and medical device companies, with $286,923 received in 2024. These payments were reported across 548 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($564,379).
As a Medicare-enrolled provider, White has provided services to 2,614 Medicare beneficiaries, totaling 2,908 services with total Medicare billing of $77,443. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Chicago, IL
- Active Since 12/18/2006
- Last Updated 10/24/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1922161447
Products in Payments
- DUPIXENT (Biological) $451,813
- AIRSUPRA (Drug) $44,499
- BREZTRI (Drug) $41,621
- Xolair (Biological) $5,760
- BREZTRI AEROSPHERE (Drug) $2,800
- DUPIXENT DUPILUMAB INJECTION (Biological) $2,793
- ALAIR (Device) $183.87
- NUCALA (Biological) $180.70
- KRYSTEXXA (Drug) $120.94
- FASENRA (Drug) $90.21
- XOLAIR (Biological) $81.94
- TEZSPIRE (Biological) $76.79
- CINQAIR (Drug) $61.22
- GLASSIA (Biological) $53.06
- Trios (Device) $48.68
- Cimzia (Drug) $30.24
- KEVZARA (Drug) $22.86
- Actemra (Biological) $20.58
- Trilogy 100 (Device) $20.47
- INFLECTRA (Biological) $20.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chicago
Douglas Hogarth
Pulmonary Disease — Payments: $3.0M
Pulmonary Disease $3.0M
Septimiu Murgu
Pulmonary Disease — Payments: $1.0M
Pulmonary Disease $1.0M
Ayodeji Adegunsoye
Pulmonary Disease — Payments: $504,729
Pulmonary Disease $504,729
Brian Garibaldi, M.d, M.D
Pulmonary Disease — Payments: $355,981
Pulmonary Disease $355,981
Dr. Ravi Kalhan, M.d, M.D
Pulmonary Disease — Payments: $327,619
Pulmonary Disease $327,619
Manu Jain, Md, MD
Pulmonary Disease — Payments: $314,772
Pulmonary Disease $314,772